Wanlin Cui

Dr. Wanlin Cui

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 June 2026 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
HCHaitao Chu
Haitao Chu
XSXin Song
Xin Song
CLChang Liu
Chang Liu
TMTianjiao Ma
Tianjiao Ma
WCWanlin Cui
Wanlin Cui
The gut microbiota exerts broad control over host physiology through tightly coordinated metabolic networks. Among these, bile salt hydrolase (BSH), a microbial enzyme, serves as a key mediator of microbiota–host crosstalk. As a key upstream gateway reaction in bile acid metabolism, BSH hydrolyzes conjugated bile acids and reshapes the composition and distribution of the intestinal bile acid pool. This remodeling alters bile acid signaling quality and influences the host energy metabolism, immune homeostasis and intestinal barrier integrity. In this review, we summarize the core biological functions and molecular regulatory mechanisms of microbial BSH in maintaining digestive system homeostasis. We further discuss the association between BSH dysregulation and the development of major digestive diseases, including metabolic dysfunction–associated steatotic liver disease (MASLD), inflammatory bowel disease (IBD) and colorectal cancer (CRC). Finally, we outline emerging precision strategies targeting BSH, including strain-specific probiotics, enzyme activity modulators and dietary interventions. These approaches offer a conceptual framework for microbiota-based therapies in digestive diseases.

30 January 2026 in Frontiers in Cellular and Infection Microbiology
Verified
Journal Article
Open access
PDF file
SPShen Pan
Shen Pan
HZHehe Zhu
Hehe Zhu
RYRui Yin
Rui Yin
JLJiaman Lin
Jiaman Lin
ZWZhujun Wang
Zhujun Wang
BLBitian Liu
Bitian Liu
Bladder cancer remains a significant global health concern, with environmental carcinogen exposure—particularly from tobacco-derived compounds such as aromatic amines, polycyclic aromatic hydrocarbons (PAHs), and nitrosamines—recognized as a primary etiological factor. These carcinogens undergo complex metabolic activation in the liver, bladder epithelium, and gut microbiota, generating reactive intermediates that initiate DNA damage, oxidative stress, and pro-tumorigenic signaling. This review synthesizes emerging evidence on how carcinogen-induced metabolic reprogramming contributes to bladder cancer initiation and progression, emphasizing the roles of key genetic pathways and metabolic enzymes involved in xenobiotic detoxification, DNA repair, and redox regulation. In parallel, we examine the influence of gut microbiota on carcinogen bioactivation and biotransformation, highlighting its dual role as both a metabolic modulator and a potential preventive target. We critically evaluate human observational data linking microbiome dysbiosis to bladder cancer risk, while addressing limitations such as small cohort sizes and confounders like diet and age. Finally, we discuss promising strategies for risk mitigation, including microbiome-directed interventions, dietary modulation, and chemopreventive agents that counteract carcinogenic effects. By integrating molecular oncology, toxicogenomics, and host-microbiome interactions, this review provides a mechanistic framework for understanding bladder cancer etiology and identifies novel opportunities for preventive and precision interventions.

16 October 2024 in The Lancet Child & Adolescent Health
Verified
Journal Article
Closed access
WCWanlin Cui
Wanlin Cui

8 September 2026 in Molecular Medicine
Verified
Journal Article
Open access
PDF file
CLChang Liu
Chang Liu
BLBitian Liu
Bitian Liu
WCWanlin Cui
Wanlin Cui
Acute kidney injury (AKI) is a complex and heterogeneous clinical syndrome characterized by dynamic pathophysiological progression and high morbidity. Emer